ConductScience.org, home

Paper36980546

Progress toward Better Treatment of Therapy-Related AML.

Kotsiafti A and 3 others. Cancers (Basel), 2023. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Progress toward Better Treatment of Therapy-Related AML. Papers, record 36980546. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36980546

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Progress toward Better Treatment of Therapy-Related AML.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
1.03
iCite
Revised in PubMed
2023-03-31
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kotsiafti AAngeliki
2Giannakas KKonstantinos
3Christoforou PPanagiotishttps://orcid.org/0000-0003-3121-7256
4Liapis KKonstantinoshttps://orcid.org/0000-0003-1165-9639

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References117

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129079594Chromothripsis is linked to TP53 alteration, cell cycle impairment, and dismal outcome in acute myeloid leukemia with complex karyotype.Haematologica2018https://conductscience.org/library/papers/29079594PubMed
22530586Wild-type p53 can inhibit oncogene-mediated focus formation.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2530586PubMed
318286528Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.Cancer2008https://conductscience.org/library/papers/18286528PubMed
434830877Management of Acute Myeloid Leukemia: Current Treatment Options and Future Perspectives.Cancers (Basel)2021https://conductscience.org/library/papers/34830877PubMed
535108372Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome.Blood2022https://conductscience.org/library/papers/35108372PubMed
629922294Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α-TNF Receptor-2 Pathway.Front Immunol2018https://conductscience.org/library/papers/29922294PubMed
735063965Impact of FLT3 Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid Leukemia.Clin Cancer Res2022https://conductscience.org/library/papers/35063965PubMed
835797463Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.Blood2022https://conductscience.org/library/papers/35797463PubMed
925757676Toward a better management of older patients with acute myeloid leukemia.Future Oncol2015https://conductscience.org/library/papers/25757676PubMed
1021127174The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML.Blood2011https://conductscience.org/library/papers/21127174PubMed
1134492705Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy.Blood Adv2021https://conductscience.org/library/papers/34492705PubMed
1221039422Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.Br J Pharmacol2011https://conductscience.org/library/papers/21039422PubMed
1332366443Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic Risk.Anticancer Res2020https://conductscience.org/library/papers/32366443PubMed
141574116A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.Nature1992https://conductscience.org/library/papers/1574116PubMed
1535884517Targeting Acute Myeloid Leukemia with Venetoclax; Biomarkers for Sensitivity and Rationale for Venetoclax-Based Combination Therapies.Cancers (Basel)2022https://conductscience.org/library/papers/35884517PubMed
1633123685Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia.Nat Cancer2020https://conductscience.org/library/papers/33123685PubMed
1725550361Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.Blood2015https://conductscience.org/library/papers/25550361PubMed
1831203995Current status and new treatment approaches in TP53 mutated AML.Best Pract Res Clin Haematol2019https://conductscience.org/library/papers/31203995PubMed
1931547736CPX-351 (vyxeos) in AML.Leuk Lymphoma2020https://conductscience.org/library/papers/31547736PubMed
2017401429Transcription regulation by mutant p53.Oncogene2007https://conductscience.org/library/papers/17401429PubMed

See all 117 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42938371
Diagnostic and Clinical Considerations in Myeloid Neoplasms with del(5q): Distinguishing Myelodysplastic Neoplasm with Low Blasts and del(5q) from Myeloid Neoplasms with del(5q) Post-Cytotoxic Therapy.
Genes (Basel)2026https://conductscience.org/library/papers/42938371PubMed
42835595Therapy-related acute myeloid leukemia with a rare complex karyotype following first-line therapy for small cell lung cancer: A case report.Oncol Lett2026https://conductscience.org/library/papers/42835595PubMed
42582651Development of acute myeloid leukemia (AML) in two breast cancer patients undergoing treatment with long-term palbociclib: a dual case report.Transl Breast Cancer Res2026https://conductscience.org/library/papers/42582651PubMed
42523532Therapy-related myelodysplastic syndrome rapidly evolving to acute myeloid leukemia following CAR-T cell therapy in a patient with refractory diffuse large B-cell lymphoma: a case report.Front Oncol2026https://conductscience.org/library/papers/42523532PubMed
42239898Prognostic heterogeneity in ASXL1-mutated AML and refinement by an immunophenotype-based score.Front Oncol2026https://conductscience.org/library/papers/42239898PubMed
42063707Concurrent therapy-related acute myeloid leukemia and lymph node tuberculosis following treatment for lung squamous cell carcinoma: a case report and literature review.Front Oncol2026https://conductscience.org/library/papers/42063707PubMed
42056941Clinical characteristics and prognosis of therapy-related acute myeloid leukemia patients with RUNX1::RUNX1T1.BMC Cancer2026https://conductscience.org/library/papers/42056941PubMed
41853304Therapy-related acute myeloid leukemia following successful treatment of high-risk neuroblastoma in a pediatric patient: a case report and insights into late complications.Front Oncol2026https://conductscience.org/library/papers/41853304PubMed
40676693Global burden and trends of hematologic malignancies based on Global Cancer Observatory 2022 and Global Burden of Disease 2021.Exp Hematol Oncol2025https://conductscience.org/library/papers/40676693PubMed
38541635Recent Advances towards the Understanding of Secondary Acute Myeloid Leukemia Progression.Life (Basel)2024https://conductscience.org/library/papers/38541635PubMed

Download CSV of cited by

Genes89

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ANPEP290PubTator's text mininghttps://conductscience.org/library/genes/290NCBI Gene
ASXL1171023PubTator's text mininghttps://conductscience.org/library/genes/171023NCBI Gene
BAX581PubTator's text mininghttps://conductscience.org/library/genes/581NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BCL2L1598PubTator's text mininghttps://conductscience.org/library/genes/598NCBI Gene
BCOR54880PubTator's text mininghttps://conductscience.org/library/genes/54880NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
CASP1834PubTator's text mininghttps://conductscience.org/library/genes/834NCBI Gene
CBFB865PubTator's text mininghttps://conductscience.org/library/genes/865NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD33945PubTator's text mininghttps://conductscience.org/library/genes/945NCBI Gene
CD3E916PubTator's text mininghttps://conductscience.org/library/genes/916NCBI Gene
CD47961PubTator's text mininghttps://conductscience.org/library/genes/961NCBI Gene
CDA978PubTator's text mininghttps://conductscience.org/library/genes/978NCBI Gene
CDKN1A1026PubTator's text mininghttps://conductscience.org/library/genes/1026NCBI Gene
CEBPA1050PubTator's text mininghttps://conductscience.org/library/genes/1050NCBI Gene
CEBPZ10153PubTator's text mininghttps://conductscience.org/library/genes/10153NCBI Gene
CHEK211200PubTator's text mininghttps://conductscience.org/library/genes/11200NCBI Gene

See all 89 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36980546

GET https://conductscience.org/api/papers/v1/36980546/references?page=2